La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Touyun Biotech Group Gestione
Gestione criteri di controllo 2/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Amy Ha
Amministratore delegato
n/a
Compenso totale
| Percentuale dello stipendio del CEO | n/a |
| Mandato del CEO | 2.7yrs |
| Proprietà del CEO | n/a |
| Durata media del management | 5.2yrs |
| Durata media del Consiglio di amministrazione | 7.8yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Revenues Not Telling The Story For Touyun Biotech Group Limited (HKG:1332) After Shares Rise 29%
Sep 15
Touyun Biotech Group Limited's (HKG:1332) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Jul 17Risks Still Elevated At These Prices As Touyun Biotech Group Limited (HKG:1332) Shares Dive 28%
Apr 22Would Touyun Biotech Group (HKG:1332) Be Better Off With Less Debt?
Apr 08What Touyun Biotech Group Limited's (HKG:1332) 46% Share Price Gain Is Not Telling You
Feb 07Some Touyun Biotech Group Limited (HKG:1332) Shareholders Look For Exit As Shares Take 42% Pounding
Dec 18Touyun Biotech Group (HKG:1332) Is Carrying A Fair Bit Of Debt
Sep 19Risks To Shareholder Returns Are Elevated At These Prices For Touyun Biotech Group Limited (HKG:1332)
Jul 28Here's Why Touyun Biotech Group (HKG:1332) Can Afford Some Debt
Sep 13Touyun Biotech Group (HKG:1332) Is Making Moderate Use Of Debt
May 18Here's Why Touyun Biotech Group (HKG:1332) Can Afford Some Debt
Dec 24Could The China Touyun Tech Group Limited (HKG:1332) Ownership Structure Tell Us Something Useful?
Mar 12If You Had Bought China Touyun Tech Group (HKG:1332) Shares A Year Ago You'd Have Earned 380% Returns
Jan 15
The Executive Chairman of China Touyun Tech Group Limited (HKG:1332), Liang Wang, Just Bought 8.8% More Shares
Jan 15How Much Of China Touyun Tech Group Limited (HKG:1332) Do Insiders Own?
Dec 11AMMINISTRATORE DELEGATO
Amy Ha (52 yo)
2.7yrs
Mandato
Ms. Amy Ha (Former name: Ha Man) is Chief Executive Officer of Touyun Biotech Group Limited from January 03, 2022. She has extensive experiences in the financial management and investment. From April 1998...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Executive Chairman | 8yrs | HK$3.60m | 27.35% HK$ 136.6m | |
| Executive Director | 7.8yrs | HK$1.22m | Nessun dato | |
| Chief Executive Officer | 2.7yrs | Nessun dato | Nessun dato | |
| Company Secretary | 2.1yrs | Nessun dato | Nessun dato |
5.2yrs
Durata media
41.5yo
Età media
Gestione esperta: Il team dirigenziale di 1332 è esperto e expertise (durata media dell'incarico 5.1 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Executive Chairman | 8yrs | HK$3.60m | 27.35% HK$ 136.6m | |
| Executive Director | 7.8yrs | HK$1.22m | Nessun dato | |
| Independent Non-Executive Director | 9.8yrs | HK$248.00k | Nessun dato | |
| Independent Non-Executive Director | 9.8yrs | HK$248.00k | Nessun dato | |
| Independent Non-Executive Director | 9.1yrs | HK$248.00k | Nessun dato | |
| Non-Executive Director | 7.8yrs | HK$240.00k | Nessun dato | |
| Independent Non-Executive Director | 3.8yrs | HK$100.00k | Nessun dato | |
| Non-Executive Director | 4.4yrs | HK$120.00k | 5.2% HK$ 26.0m | |
| Non-Executive Director | 3.8yrs | HK$978.00k | Nessun dato | |
| Non-Executive Director | 3.8yrs | HK$20.00k | 0.036% HK$ 178.0k |
7.8yrs
Durata media
44.5yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 1332 sono considerati esperti (durata media dell'incarico 7.7 anni).